BACKGROUND:Acute tryptophan (TRP) depletion was evaluated in healthy volunteers with or without a family history of major affective disorder (FH+ versus FH-). METHODS:Twenty-seven subjects (16 FH+, 11 FH-) received 100 g of anamino acid mixture with and without TRP according to a placebo-controlled, double-blind cross-over design and a diet devoid of TRP for the next 24 hours. RESULTS: The ratio TRP/large neutral amino acids declined to 22% of baseline values after 6 hours, and increased during the night reaching 85% of baseline after 24 hours. Overall, after 6 hours, TRP depletion lead to a lowering of mood, but after 24 hours, these changes were no longer detected. Mood changes and gastrointestinal side effects were significantly more evident in FH+ subjects than in FH- subjects. CONCLUSIONS: Our data support the hypothesis that subjects with a positive family history for depression are predisposed to increased vulnerability to the adverse consequences of serotonergic imbalance.
RCT Entities:
BACKGROUND: Acute tryptophan (TRP) depletion was evaluated in healthy volunteers with or without a family history of major affective disorder (FH+ versus FH-). METHODS: Twenty-seven subjects (16 FH+, 11 FH-) received 100 g of an amino acid mixture with and without TRP according to a placebo-controlled, double-blind cross-over design and a diet devoid of TRP for the next 24 hours. RESULTS: The ratio TRP/large neutral amino acids declined to 22% of baseline values after 6 hours, and increased during the night reaching 85% of baseline after 24 hours. Overall, after 6 hours, TRP depletion lead to a lowering of mood, but after 24 hours, these changes were no longer detected. Mood changes and gastrointestinal side effects were significantly more evident in FH+ subjects than in FH- subjects. CONCLUSIONS: Our data support the hypothesis that subjects with a positive family history for depression are predisposed to increased vulnerability to the adverse consequences of serotonergic imbalance.
Authors: Eileen Daly; Quinton Deeley; Brian Hallahan; Michael Craig; Michael Brammer; Melissa Lamar; Anthony Cleare; Vincent Giampietro; Christine Ecker; Lisa Page; Fiona Toal; Mary L Phillips; Simon Surguladze; Declan G M Murphy Journal: Psychopharmacology (Berl) Date: 2010-04-28 Impact factor: 4.530
Authors: Hamid A Alhaj; Matthew Selman; Victoria Jervis; Jacqui Rodgers; Stephen Barton; R Hamish McAllister-Williams Journal: Psychopharmacology (Berl) Date: 2012-07 Impact factor: 4.530
Authors: Matthew S Milak; Spiro Pantazatos; Rain Rashid; Francesca Zanderigo; Christine DeLorenzo; Natalie Hesselgrave; R Todd Ogden; Maria A Oquendo; Stephanie T Mulhern; Jeffrey M Miller; Ainsley K Burke; Ramin V Parsey; J John Mann Journal: Psychiatry Res Neuroimaging Date: 2018-04-13 Impact factor: 2.376
Authors: Frederik M van der Veen; Gabry W Mies; Maurits W van der Molen; Elisabeth A Evers Journal: Psychopharmacology (Berl) Date: 2008-05-28 Impact factor: 4.530
Authors: Donald M Dougherty; Dawn M Marsh-Richard; Charles W Mathias; Ashley J Hood; Merideth A Addicott; F Gerard Moeller; Christopher J Morgan; Abdulla A-B Badawy Journal: Psychopharmacology (Berl) Date: 2008-05-02 Impact factor: 4.530